Our work illustrates the importance of Des1 inhibitors as host-directed antiviral agents, reveals the crucial role of dhSMs in flavivirus infection, and contributes to expanding the portfolio of the roles and functions of dihydrosphingolipids beyond their implication in cancer and metabolic diseases. Here, DEGS1 is linked to metabolic disease.